🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators aim to investigate whether incorporating on-treatment EBV...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-06-01
Trial ID
NCT04072107
Treatments Being Tested
The purpose of this observational study is to evaluate the impact of differ...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT07098104
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of si...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2021-03-10
Trial ID
NCT04675983
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2021-12-01
Trial ID
NCT04514835
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and effi...
Status
Completed
Location
The fifth medical center of the PLA general hospital
Start Date
2016-10-19
Trial ID
NCT02937116
Based on the interaction between radiation therapy and immunotherapy and th...
Status
Recruiting
Location
Zhengjiang Cancer Hospital
Start Date
2024-03-20
Trial ID
NCT06349044
This is a prospective, open-label, exploratory, phase II basket clinical tr...
Status
Not Yet Recruiting
Location
Tongji Hospital
Start Date
2025-08-15
Trial ID
NCT07053150
Treatments Being Tested
The treatment efficacy for stage IVb esophageal cancer has been improved th...
Status
Recruiting
Location
Cancer hospital, CAMS
Start Date
2023-10-16
Trial ID
NCT06084897
This is a Phase II, randomized, multicenter, open-label clinical trial desi...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2024-10-17
Trial ID
NCT06730373
Treatments Being Tested